Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 25 April 2022
Sec. Cardiovascular Metabolism
Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.913429

Corrigendum: miR-21 in Human Cardiomyopathies

\n Surina Surina1Rosaria Anna FontanellaRosaria Anna Fontanella1Lucia ScisciolaLucia Scisciola1Raffaele Marfella,Raffaele Marfella1,2Giuseppe Paolisso,Giuseppe Paolisso1,2Michelangela Barbieri Michelangela Barbieri1*
  • 1Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
  • 2Mediterrannea Cardiocentro, Napoli, Italy

A Corrigendum on
miR-21 in Human Cardiomyopathies

by Surina., Fontanella, R. A., Scisciola, L., Marfella, R., Paolisso, G., and Barbieri, M. (2021). Front. Cardiovasc. Med. 8:767064. doi: 10.3389/fcvm.2021.767064

An author name was incorrectly spelled as “Surina Surina.” The correct spelling is “Surina.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: miR-21, cardiomyopathies, biomarkers, targeted therapy, fibrosis

Citation: Surina, Fontanella RA, Scisciola L, Marfella R, Paolisso G and Barbieri M (2022) Corrigendum: miR-21 in Human Cardiomyopathies. Front. Cardiovasc. Med. 9:913429. doi: 10.3389/fcvm.2022.913429

Received: 05 April 2022; Accepted: 06 April 2022;
Published: 25 April 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Surina, Fontanella, Scisciola, Marfella, Paolisso and Barbieri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michelangela Barbieri, bWljaGVsYW5nZWxhLmJhcmJpZXJpJiN4MDAwNDA7dW5pY2FtcGFuaWEuaXQ=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.